Biomarker Analysis Beyond Angiogenesis: RAS/RAF Mutation Status, Tumour Sidedness, and Second-Line Ramucirumab Efficacy in Patients With Metastatic Colorectal Carcinoma From RAISE, a Global Phase 3 Study
Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdy461
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2019
Authors
Publisher
Elsevier BV